SCHEMBL13086313

SCHEMBL13086313

CCCCCCCCOC(=O)c1cc(Nc2ccc3c4c2C(=O)c2ccccc2-c4c(C(C)=O)c(=O)n3C)cc(C(=O)OCCCCCCCC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PABPC1 P11940 3/20 0.49
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ POLB P06746 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ NR4A1 P22736 1/20 0.40
▸ MAP3K5 Q99683 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ USP2 O75604 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ KEAP1 Q14145 1/20 0.36
▸ PLEC Q15149 1/20 0.36
▸ NFE2L2 Q16236 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13382720 0.76 MEN1 (0.66) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL10033603 0.74 MEN1 (0.63) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL17808610 0.74 MAP3K5 (0.49) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL6825327 0.73 MAPT (0.46) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL138484 0.72 MAP3K5 (0.65) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL10033595 0.71 MEN1 (0.56) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL13382730 0.71 MEN1 (0.53) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL14559159 0.70 MAP3K5 (0.61) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL13382731 0.70 MEN1 (0.52) PABPC1MEN1KMT2APOLBL3MBTL1
SCHEMBL13993026 0.70 MAP3K5 (0.51) PABPC1MEN1KMT2APOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816422-B2 Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate FUJIFILM CORPORATION (JP) 2010-10-19 — — US disclosed
US-20100136300-A1 CURABLE COMPOSITION, INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING PLATE AND OXETANE COMPOUND FUJIFILM CORPORATION (JP) 2010-06-03 — — US disclosed
US-7709550-B2 Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate FUJIFILM CORPORATION (JP) 2010-05-04 — — US disclosed
US-7703907-B2 Ink composition, inkjet-recording method and printed material FUJIFILM CORPORATION (JP) 2010-04-27 — — US disclosed
US-20090068415-A1 INK COMPOSITION, IMAGE-FORMING METHOD AND RECORDED MEDIUM FUJIFILM CORPORATION (JP) 2009-03-12 — — US disclosed
US-20070132810-A1 Ink composition, inkjet recording method, printed material, production method of planographic printing plate, and planographic printing plate FUJIFILM CORPORATION (JP) 2007-06-14 — — US disclosed
US-20070071952-A1 Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate FUJI PHOTO FILM CO., LTD. 2007-03-29 — — US disclosed
US-20070052790-A1 Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate FUJI PHOTO FILM CO., LTD. 2007-03-08 — — US disclosed
US-20070049651-A1 Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, planographic printing plate, and oxcetane compound FUJI PHOTO FILM CO., LTD. 2007-03-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100136300-A1 CURABLE COMPOSITION, INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING PLATE AND OXETANE COMPOUND CCNT1, ACVR2B, ACVR1B PABPC1 3268/4885MEN1 2235/4885KMT2A 726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback